Not Enough Americans Being Screened for Cancer

Not Enough Americans Being Screened for Cancer
Not Enough Americans Being Screened for Cancer

THURSDAY, Jan. 26 (HealthDay News) -- U.S. residents are not being screened for cancer at the recommended levels, and screening rates vary by several demographic factors, according to research published in the Jan. 27 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

Carrie N. Klabunde, Ph.D., of the CDC in Atlanta, and colleagues analyzed data from the 2010 National Health Interview Survey to assess the use of recommended cancer screening tests by U.S. residents, identify population subsets not receiving the full benefits of screening, and target interventions that could boost screening rates in those groups.

The researchers found that screening rates for breast, cervical, and colorectal cancer fell short of the Healthy People 2020 screening goals. All three types of cancer screening were significantly lower in Asians than in white and black populations, and Hispanics were less likely to undergo cervical and colorectal cancer screening. People were more likely to be screened if they had higher education, greater access to health care, and longer duration of U.S. residence.

"Continued monitoring of screening rates helps to assess progress toward meeting Healthy People 2020 targets and to develop strategies to reach those targets," the authors write.

Full Text

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs